Arizona out to spawn new biotechs

Arizona officials have always talked an ambitious game plan for fostering its fledgling biotech sector. Now a biotechnology incubator and life sciences association in Arizona has launched the ThirdBiotech Research Group, which includes a drug discovery research institute and technology incubator for the promotion of collaborative activities between researchers and industry.

"The group's mission is to form and establish biotech companies based in Arizona by working with collaborative partners, researchers and investors," said Jeff Morhet, CEO of InNexus Biotechnology and founder of ThirdBiotech.

- check out the press release

Suggested Articles

Zydus Cadila has completed a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 .

OrbiMed, Novartis Venture Fund and RA Capital Management have joined forces to fund and help launch GentiBio.

A month after scoring $1.6 billion from the U.S. government, Novavax is posting the first human data from its COVID-19 vaccine.